MGLJX | RRGIX | MGLJX / RRGIX | |
Total Expense Ratio | 1.94 | 0.95 | 204% |
Annual Report Gross Expense Ratio | 1.95 | 1.03 | 189% |
Fund Existence | 11 years | 19 years | - |
Gain YTD | 3.017 | 6.122 | 49% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 1000000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.22B | 160M | 1,384% |
Annual Yield % from dividends | 1.53 | 2.73 | 56% |
Returns for 1 year | 1.38 | 7.82 | 18% |
Returns for 3 years | -6.39 | 11.27 | -57% |
Returns for 5 years | 9.35 | 23.83 | 39% |
Returns for 10 years | 11.47 | 22.46 | 51% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
HAGAX | 76.30 | 0.69 | +0.91% |
Carillon Eagle Mid Cap Growth A | |||
VYMSX | 19.96 | 0.17 | +0.86% |
Voya Mid Cap Research Enhanced Index I | |||
GLCRX | 30.25 | 0.18 | +0.60% |
Goldman Sachs Large Cap Gr Insghts R | |||
GCVCX | 24.22 | 0.07 | +0.29% |
Goldman Sachs Large Cp Val Insghts C | |||
LHCSX | 18.35 | 0.05 | +0.27% |
Lord Abbett Health Care R4 |